Mark George

2.9k total citations
33 papers, 1.5k citations indexed

About

Mark George is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Mark George has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Mark George's work include Colorectal Cancer Surgical Treatments (8 papers), Anorectal Disease Treatments and Outcomes (7 papers) and Angiogenesis and VEGF in Cancer (4 papers). Mark George is often cited by papers focused on Colorectal Cancer Surgical Treatments (8 papers), Anorectal Disease Treatments and Outcomes (7 papers) and Angiogenesis and VEGF in Cancer (4 papers). Mark George collaborates with scholars based in United Kingdom, United States and France. Mark George's co-authors include R I Swift, Matthew G. Tutton, A S K Dzik-Jurasz, Gina Brown, Anwar R. Padhani, S. A. Eccles, Simon Doran, Jan Wolber, A. M. Abulafi and A. Muti Abulafi and has published in prestigious journals such as The Lancet, Nature Genetics and Biophysical Journal.

In The Last Decade

Mark George

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark George United Kingdom 16 649 546 410 387 211 33 1.5k
R I Swift United Kingdom 21 1.3k 2.0× 551 1.0× 355 0.9× 840 2.2× 196 0.9× 33 2.0k
L. Dewit Netherlands 23 506 0.8× 550 1.0× 248 0.6× 509 1.3× 121 0.6× 58 1.8k
Susan M. Hiniker United States 20 702 1.1× 224 0.4× 383 0.9× 213 0.6× 181 0.9× 108 1.6k
Yoshito Yamashita Japan 21 409 0.6× 281 0.5× 229 0.6× 562 1.5× 103 0.5× 111 1.4k
Katja Lindel Germany 22 708 1.1× 137 0.3× 322 0.8× 610 1.6× 374 1.8× 60 1.9k
Akira Shohtsu Japan 23 346 0.5× 619 1.1× 174 0.4× 377 1.0× 105 0.5× 106 1.5k
Onelio Geatti Italy 18 365 0.6× 300 0.5× 212 0.5× 376 1.0× 103 0.5× 50 1.3k
Hong‐Gyun Wu South Korea 21 336 0.5× 277 0.5× 219 0.5× 347 0.9× 115 0.5× 113 1.3k
Stella D’Oronzo Italy 21 594 0.9× 124 0.2× 421 1.0× 176 0.5× 171 0.8× 46 1.1k
N. Davidson United Kingdom 15 1.3k 2.0× 288 0.5× 358 0.9× 501 1.3× 270 1.3× 41 1.9k

Countries citing papers authored by Mark George

Since Specialization
Citations

This map shows the geographic impact of Mark George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark George more than expected).

Fields of papers citing papers by Mark George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark George. The network helps show where Mark George may publish in the future.

Co-authorship network of co-authors of Mark George

This figure shows the co-authorship network connecting the top 25 collaborators of Mark George. A scholar is included among the top collaborators of Mark George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark George. Mark George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Eun-Joo, Alfredo Erazo‐Oliveras, Natividad R. Fuentes, et al.. (2024). Diet therapy abates mutant APC and KRas effects by reshaping plasma membrane cholesterol nanodomains. Biophysical Journal. 124(3). 508–527. 1 indexed citations
3.
Hainsworth, Alison, et al.. (2023). Differences in quality of life of patients undergoing total pelvic exenteration compared with standard rectal cancer surgery: a scoping review. Colorectal Disease. 25(12). 2306–2316. 1 indexed citations
4.
Patsouras, Dimitrios, Alexis Schizas, Mark George, et al.. (2020). Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events. European Urology Focus. 7(3). 638–643. 7 indexed citations
5.
Nikolopoulos, Ioannis, et al.. (2015). Cardiopulmonary exercise testing versus spirometry as predictors of cardiopulmonary complications after colorectal surgery. European surgery. Supplement/European surgery. 47(6). 324–330. 6 indexed citations
6.
Wynn, Greg, et al.. (2009). Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. Colorectal Disease. 12(4). 327–333. 29 indexed citations
7.
Miller, Max, Roy Ng, David A. Ross, et al.. (2009). Use of myocutaneous flaps for perineal closure following abdominoperineal excision of the rectum for adenocarcinoma. Colorectal Disease. 12(6). 555–560. 74 indexed citations
8.
Anderson, O. D., et al.. (2008). Tailgut cysts: report of two cases. International Journal of Colorectal Disease. 24(3). 345–350. 27 indexed citations
9.
Ahmed, Kamran, et al.. (2008). Adenocarcinoma of the appendix presenting as bilateral ureteric obstruction. World Journal of Surgical Oncology. 6(1). 23–23. 14 indexed citations
10.
Agha, Riaz, et al.. (2007). Arterial embolisation to control haemorrhage following colonoscopic polypectomy. International Journal of Surgery. 6(5). 420–421. 2 indexed citations
11.
George, Mark, et al.. (2006). Acute colonic pseudo‐obstruction after caesarean section. The Obstetrician & Gynaecologist. 8(4). 207–213. 3 indexed citations
12.
Tutton, Matthew G., Mark George, Suzanne A. Eccles, et al.. (2003). Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patients. International Journal of Cancer. 107(4). 541–550. 110 indexed citations
13.
George, Mark, Matthew G. Tutton, A. M. Abulafi, S. A. Eccles, & R I Swift. (2002). Plasma basic fibroblast growth factor levels in colorectal cancer: A clinically useful assay?. Clinical & Experimental Metastasis. 19(8). 735–738. 22 indexed citations
14.
Murphy, Philip S., Mark George, David J. Collins, et al.. (2002). Human rectal adenocarcinoma: Demonstration of 1H‐MR spectra in vivo at 1.5 T. Magnetic Resonance in Medicine. 47(4). 809–811. 29 indexed citations
15.
Dzik-Jurasz, A S K, Mark George, Jan Wolber, et al.. (2002). Diffusion MRI for prediction of response of rectal cancer to chemoradiation. The Lancet. 360(9329). 307–308. 376 indexed citations
16.
Tutton, Matthew G., et al.. (2001). Solitary pancreatic metastasis from a primary colonic tumor detected by PET scan. Diseases of the Colon & Rectum. 44(2). 288–290. 13 indexed citations
17.
George, Mark, Matthew G. Tutton, Frank W. Janssen, et al.. (2001). VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression. Neoplasia. 3(5). 420–427. 183 indexed citations
18.
George, Mark, S. A. Eccles, Matthew G. Tutton, A. M. Abulafi, & R I Swift. (2000). Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?. PubMed. 6(8). 3147–52. 202 indexed citations
19.
Anasti, James N., Sophia Kalantaridou, Lorene M. Kimzey, Mark George, & Lawrence M. Nelson. (1998). Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles. Human Reproduction. 13(5). 1144–1147. 48 indexed citations
20.
Chauvergne, J, Jean‐François Héron, Y Aymé, et al.. (1990). [Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].. PubMed. 77(10). 1007–24. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026